The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

Stocks•16 June 2026•

2 min read

Alberta Investment Corp Boosts Kenvue Stake by 50% Following Earnings Beat

Key Facts

1Alberta Investment Management Corp increased its stake in Kenvue Inc. by 50.1% in Q4, bringing its total holdings to 1.66 million shares.

2The value of the fund's holdings in the company is approximately $28.66 million.

3Kenvue reported strong quarterly earnings of $0.32 EPS and declared a quarterly dividend of $0.2075 per share.

In a move reflecting institutional confidence in the consumer healthcare sector, Alberta Investment Management Corp increased its stake in Kenvue Inc. by 50.1% during the fourth quarter. Following this transaction, the fund's total holdings reached 1.66 million shares, with an approximate market value of $28.66 million. This investment surge follows Kenvue's strong quarterly performance, where it reported earnings of $0.32 per share and declared a quarterly dividend of $0.2075.

This expansion in institutional ownership coincides with similar moves by major investors like Sculptor Capital LP, strengthening the shareholder base of the Johnson & Johnson spinoff. Compared to peers in the consumer staples sector, Kenvue has maintained stable profit margins despite global inflationary pressures. According to market data, institutional and sovereign wealth fund interest in value stocks is rising amid current market volatility, particularly for companies committed to regular dividend payouts.

From a technical perspective, KVUE shares stood at $18.25 at close June 15, 2026, after trading between a high of $18.39 and a low of $18.08. Traders are currently monitoring support levels near $18.00, while looking ahead to the U.S. Consumer Price Index (CPI) data scheduled for June 10, 2026, which could impact risk appetite across the retail and healthcare sectors.